Thomas A Prohaska Selected Research

Single-Chain Antibodies

1/2018

Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas A Prohaska Research Topics

Disease

3	Hypertriglyceridemia 04/2024 - 05/2023
3	Atherosclerosis 01/2022 - 07/2015
2	Pancreatitis 04/2024 - 02/2024
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 04/2024 - 05/2023
2	Inflammation (Inflammations) 01/2018 - 04/2016
1	Costello Syndrome 05/2023
1	Familial Partial Lipodystrophy (Dunnigan Syndrome) 05/2023
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018
1	Obesity 04/2016
1	Insulin Resistance 04/2016
1	Glucose Intolerance 04/2016
1	Arthrogryposis renal dysfunction cholestasis syndrome 02/2015
1	ST Elevation Myocardial Infarction 02/2015
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 02/2015
1	Neoplasms (Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

4	EpitopesIBA 01/2022 - 02/2015
4	Immunoglobulin M (IgM)IBA 01/2022 - 02/2015
3	Triglycerides (Triacylglycerol)IBA 04/2024 - 05/2023
3	AntibodiesIBA 04/2016 - 02/2015
2	Apolipoprotein C-IIIIBA 04/2024 - 05/2023
2	ISIS 304801IBA 02/2024 - 05/2023
2	Apolipoproteins E (ApoE)IBA 01/2018 - 07/2015
1	HDL CholesterolIBA 04/2024
1	ApolipoproteinsIBA 04/2024
1	Antisense OligonucleotidesIBA 05/2023
1	Messenger RNA (mRNA)IBA 05/2023
1	Single-Chain AntibodiesIBA 01/2018
1	1-penicillamyl-Leu(2)- oxytocinIBA 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	CholesterolIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 04/2016
1	AntigensIBA 07/2015
1	Interleukin-8 (Interleukin 8)IBA 02/2015
1	oxidized low density lipoproteinIBA 02/2015
1	Monoclonal AntibodiesIBA 02/2015
1	TrypsinogenIBA 01/2012

Therapy/Procedure

2	Therapeutics 04/2024 - 01/2018